Discriminatory Ability of Gas Chromatography-Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis.

Joshua NazarethDaniel PanJee Whang KimJack LeachJames G BrosnanAdam AhmedEmma BrodrickPaul BirdAlfian WicaksonoEmma DaultonJulian W TangCaroline WilliamsPranabashis HaldarJames A CovingtonManish PareekAmandip Sahota

Published in: Open forum infectious diseases (2022)

GC-IMS shows promise as both a diagnostic tool and a predictor of prognosis in hospitalized patients with COVID-19 and should be assessed further in larger studies.

Keyphrases

gas chromatography
mass spectrometry
tandem mass spectrometry
coronavirus disease
end stage renal disease
newly diagnosed
ejection fraction
sars cov
high resolution mass spectrometry
gas chromatography mass spectrometry
solid phase extraction
machine learning
big data
artificial intelligence